SCHEMBL13065740

SCHEMBL13065740

O=C(O)Cc1ccc(-c2c(C(=O)O)c3nc4ccccc4oc-3c(O)c2=O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.39
POLB P06746 1/20 0.39
DHODH Q02127 4/20 0.39
ROCK2 O75116 1/20 0.39
ROCK1 Q13464 1/20 0.39
ABCC4 O15439 1/20 0.38
GAA P10253 1/20 0.38
TSHR P16473 1/20 0.38
PTGS1 P23219 1/20 0.38
HTT P42858 1/20 0.38
PDE10A Q9Y233 2/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
MITF O75030 1/20 0.37
MAPT P10636 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
GFER P55789 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16784744 0.90 PDE10A (0.40) LMNAPOLBDHODHTSHRHTT
SCHEMBL13065731 0.89 DHODH (0.47) LMNADHODHTSHRHTTPDE10A
SCHEMBL13065738 0.87 HPGD (0.42) LMNADHODHPDE10AMEN1KMT2A
SCHEMBL13065743 0.86 KDM4E (0.40) LMNAPOLBDHODHROCK2ROCK1
SCHEMBL13065735 0.86 LMNA (0.48) LMNAPOLBDHODHGAATSHR
SCHEMBL13065732 0.86 MAPK14 (0.45) LMNADHODHGAAPDE10AMEN1
SCHEMBL13065615 0.84 HPSE (0.37) POLBGAAMEN1KMT2AMAPT
SCHEMBL13065729 0.83 KDM4E (0.51) LMNADHODHMEN1KMT2AMAPT
SCHEMBL13065737 0.83 DHODH (0.39) LMNADHODHPDE10AMEN1KMT2A
SCHEMBL13065623 0.82 MEN1 (0.41) LMNAPOLBGAAHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9052324-B2 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. (US) 2015-06-09 US disclosed
US-20120322717-A9 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. 2012-12-20 US disclosed
US-20100298200-A1 Compounds and assays for controlling Wnt activity LIU DAKAI 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322717-A9 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 LMNA 4171/4885POLB 3310/4885DHODH 3278/4885
US-20100298200-A1 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 LMNA 4171/4885POLB 3310/4885DHODH 3278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.